Listed below are all new filings before the PTAB of petitions for inter partes review (IPR) and covered business methods review (CBM). Also listed are any newly-posted requests for ex parte reexamination at the USPTO. This listing is current as of 10 AM on Friday, November 4, 2016.
New IPR Petitions
Trial Number – IPR2017-00172
Filing Date – 11/3/2016
Patent # – 7,064,197
Title – SYSTEM, ARAY AND NON-POROUS SOLID SUPPORT COMPRISING FIXED OR IMMOBILIZED NUCLEIC ACIDS
Patent Owner – ENZO LIFE SCIENCES, INC.
Petitioner – BECTON, DICKINSON AND COMPANY
Tech Center – 1600
Trial Number – IPR2017-00177
Filing Date – 11/3/2016
Patent # – 8,537,279
Title – DIGITAL MICROFORM IMAGING APPARATUS
Patent Owner – E-IMAGEDATA CORP.
Petitioner – DIGITAL CHECK CORP. d/b/a ST IMAGING
Tech Center – 2400
Trial Number – IPR2017-00178
Filing Date – 11/3/2016
Patent # – 9,179,019
Title – DIGITAL MICROFORM IMAGING APPARATUS
Patent Owner – E-IMAGEDATA CORP.
Petitioner – DIGITAL CHECK CORP. d/b/a ST IMAGING
Tech Center – 2400
Trial Number – IPR2017-00181
Filing Date – 11/3/2016
Patent # – 7,064,197
Title – SYSTEM, ARAY AND NON-POROUS SOLID SUPPORT COMPRISING FIXED OR IMMOBILIZED NUCLEIC ACIDS
Patent Owner – ENZO LIFE SCIENCES, INC.
Petitioner – BECTON, DICKINSON AND COMPANY
Tech Center – 1600
New CBM Review Petitions
There have been no new petitions for CBM review since the last report.
Newly-Posted Reexam Requests
Control # – 90/013,857
Date – 11/3/2016
Patent # – 8,772,964
Inventor – BEG, Mirza Akmal
Assignee – SCHNEIDER ELECTRIC IT CORPORATION
Title – PARALLEL CONTROL AND PROTECTION FOR UPS
Co-pending Litigation – No co-pending litigation provided.
Control # – 90/013,858
Date – 11/3/2016
Patent # – 8,558,055
Inventor – OSTERTAG, Eric M. et al.
Assignee – TRANSPOSAGEN BIOPHARMACEUTICALS, INC.
Title – A GENETICALLY MODIFIED RAT COMPRISING A CYTOKINE GENE DISRUPTION AND EXHIBITING A GREATER SUSCEPTIBILITY TO A CYTOKINE-MEDIATED AUTOIMMUNE AND/OR INFLAMMATORY DISEASE
Co-pending Litigation – SAGE Labs, Inc. v. Transposagen Biopharmaceuticals, Inc., DED-1-15-cv-00791